Nathalie Harder
Hat mitgewirkt an:
-
Automatic cell cycle analysis based on live cell fluorescence microscopy image sequences
-
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer
-
Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma
-
Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer